Implanet’s new subsidiary targets $300M market: 4 things to know

Vertebral and knee surgery implant company Implanet established a German subsidiary.

Advertisement

Here are four things to know:

1. The German degenerative spine disease market is estimated at $300 million, with approximately 1,000 potential surgeon customers.

2. Implanet’s new German branch will set up a mixed network of direct sales representatives and exclusive sales agents.

3. Implanet opened a United Kingdom sales branch in June.

4. According to Implanet CEO Ludovic Lastennet, the company’s 2018-19 strategic plan involves promoting Implanet’s product range directly in key European markets and preparing to integrate the products of its partner L&K Biomed.

More articles on devices:

Stryker reports $3.3B in Q2 sales, neurotechnology & spine segment experiences 19.4% uptick: 6 things to know

Medtronic, Titan Spine, Wright Medical & more: 9 device company notes

US House repeals sales tax on medical devices: 4 details to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.